Found 18 matching trials
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial PHASE3 The overall aim of this research is to improve secondary stroke prevention ...
Show More Location
Multiple Locations
Learn More & Join Trial
Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting N/A New brain ischemic lesions are detected in about 50% of patients undergoing...
Show More Location
University Hospital Ostrava
Learn More & Join Trial
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) PHASE4 In patients with heart attacks, the current standard of care is to restore ...
Show More Location
University of Ottawa Heart Institute
Learn More & Join Trial
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen PHASE4 Objectives
1. To compare the safety and long-term effectiveness of coronar...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement NA 100 subjects in the each of the treatment arms of the study (total 200 trea...
Show More Location
Foundation for Cardiovascular Medicine
Learn More & Join Trial
High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay NA High on-treatment platelet reactivity to adenosine diphosphate was a import...
Show More Location
Wuhan Asia Heart Hospital
Learn More & Join Trial
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome PHASE4 To compare treatment with Aspirin Protect® twice a day (100 mg in the morni...
Show More Location
Department of Cardiology - Lariboisiere Hospital
Learn More & Join Trial
LAAO Versus NOAC in Patients with AF and PCI NA Atrial fibrillation (AF) coincides with coronary artery disease (CAD) share...
Show More Learn More & Join Trial
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? PHASE4 The optimal antithrombotic management in patients with coronary artery dise...
Show More Learn More & Join Trial
Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes PHASE3 To assess whether a rivaroxaban-based anticoagulation strategy, following s...
Show More Location
Multiple Locations
Learn More & Join Trial